Live from the NIH registry
Studies recruiting near Cape Coral right now
Top 25 of 236 recruiting studies, sorted by proximity — each links to its official registry page
Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3)
Vulvar Diseases, HPV Infection
Phase 2
Interventional 27 participants sought
Florida Gynecologic Oncology — Fort Myers, Florida (9.7 mi)
· Sponsor: Frantz Viral Therapeutics, LLC
RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
Focal Onset Seizures
Phase 2
Interventional 216 participants sought
Medsol Clinical Research Center — Port Charlotte, Florida (23.7 mi)
· Sponsor: Supernus Pharmaceuticals, Inc.
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Ovarian Cancer, Fallopian Tube Cancer
Phase 2
Interventional 270 participants sought
544 — Fort Myers, Florida (9.7 mi)
· Sponsor: Corcept Therapeutics
A Rollover Study Evaluating Sotorasib With or Without Panitumumab in Participants With KRAS p.G12C Mutation
Advanced Solid Tumors
Phase 2
Interventional 14 participants sought
Florida Cancer Specialists - Fort Myers — Fort Myers, Florida (9.7 mi)
· Sponsor: Amgen
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma
Phase 3
Interventional 5,951 participants sought
Golisano Children's Hospital of Southwest Florida — Fort Myers, Florida (9.7 mi)
· Sponsor: Children's Oncology Group
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
Spinal Muscular Atrophy (SMA)
N/A
Observational 700 participants sought
Golisano Children's Hospital of Southwest Florida — Fort Myers, Florida (9.7 mi)
· Sponsor: Novartis Pharmaceuticals
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Childhood Medulloblastoma
Phase 3
Interventional 225 participants sought
Golisano Children's Hospital of Southwest Florida — Fort Myers, Florida (9.7 mi)
· Sponsor: Children's Oncology Group
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Breast Neoplasms, Triple Negative Breast Neoplasms
Phase 3
Interventional 2,400 participants sought
Florida Cancer Specialists - South ( Site 7004) — Fort Myers, Florida (9.7 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
GenesisCare USA - FGO — Fort Myers, Florida (9.7 mi)
· Sponsor: NRG Oncology
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Heart Failure, Acute Heart Failure
Phase 3
Interventional 5,200 participants sought
Fort Myers, FL Investigative Site 10076 — Fort Myers, Florida (9.7 mi)
· Sponsor: Colorado Prevention Center
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)
Psychosis Associated With Alzheimer's Disease
Phase 3
Interventional 500 participants sought
Local Institution - 1165 — Fort Myers, Florida (9.7 mi)
· Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 3
Interventional 2,150 participants sought
Akero Clinical Study Site — Fort Myers, Florida (9.7 mi)
· Sponsor: Akero Therapeutics, Inc
Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy
Diabetic Peripheral Neuropathic Pain
Phase 2
Interventional 300 participants sought
AMR Fort Myers (The Clinical Study Center) — Fort Myers, Florida (9.7 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
Diabetic Peripheral Neuropathic Pain
Phase 3
Interventional 1,100 participants sought
AMR Fort Myers (The Clinical Study Center) — Fort Myers, Florida (9.7 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
Phase 2
Interventional 250 participants sought
Florida Cancer Specialists - South — Fort Myers, Florida (9.7 mi)
· Sponsor: SCRI Development Innovations, LLC
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Mitral Valve Regurgitation
N/A
Interventional 1,056 participants sought
HealthPark Medical Center — Fort Myers, Florida (9.7 mi)
· Sponsor: Medtronic Cardiovascular
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 1,200 participants sought
Florida Cancer Specialists - South ( Site 7001) — Fort Myers, Florida (9.7 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
Schizophrenia, Schizoaffective Disorder
Phase 4
Interventional 100 participants sought
Neurocrine Clinical Site — Port Charlotte, Florida (23.7 mi)
· Sponsor: Neurocrine Biosciences
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Neoplasms
Phase 3
Interventional 1,314 participants sought
Florida Cancer Specialists - South ( Site 7003) — Fort Myers, Florida (9.7 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Colorectal Neoplasms
Phase 3
Interventional 1,000 participants sought
Florida Cancer Specialists South — Fort Myers, Florida (9.7 mi)
· Sponsor: Janssen Research & Development, LLC
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Heart Failure
Phase 3
Interventional 4,200 participants sought
Peace River Cardiovascular Center — Port Charlotte, Florida (23.7 mi)
· Sponsor: Boehringer Ingelheim
A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
Hidradenitis Suppurativa
Phase 2
Interventional 144 participants sought
Alliance for Multispeciality Research - Fort Myers- Site Number : 8400007 — Fort Myers, Florida (9.7 mi)
· Sponsor: Sanofi
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Type 2 Diabetes, Cortisol Excess
Phase 2
Interventional 1,500 participants sought
Innovative Research Institute — Port Charlotte, Florida (23.7 mi)
· Sponsor: Sparrow Pharmaceuticals
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
Bipolar Depression
Phase 3
Interventional 384 participants sought
Royal Palm Clinical Research — Fort Myers, Florida (9.7 mi)
· Sponsor: Intra-Cellular Therapies, Inc.
A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients (LiGeR-HN2)
Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 600 participants sought
Site 12 — Fort Myers, Florida (9.7 mi)
· Sponsor: Merus B.V.